| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/12/2022 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $1.24 | $31k | | 05/12/2022 |
| 05/12/2021 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $23.25 | $581.2k | | 05/12/2021 |
| 05/21/2020 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $6.22 | $155.5k | | 05/21/2020 |
| 05/23/2019 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $16.27 | $406.8k | | 05/23/2019 |
| 07/20/2018 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 10k | $23.00 | $230k | | 07/20/2018 |
| 07/17/2018 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $23.00 | $575k | | 07/17/2018 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Performance Shares | 34.2k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Performance Shares | 8.8k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Performance Shares | 779.4267 | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Performance Shares | 7.2k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Performance Shares | 288.827 | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Common Stock, $0.10 par value | 2k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Common Stock, $0.10 par value | 1.6k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Common Stock, $0.10 par value | 416 | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 1.3k | $37.53 | $47.9k | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 2k | $37.53 | $74.6k | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 2.3k | $37.53 | $86.3k | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 16.6k | $37.53 | $622.1k | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Market Share Units | 3.7k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Market Share Units | 4.1k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Market Share Units | 3k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Performance Shares | 9.9k | $0.00 | $0 | | 03/07/2013 |
| 03/07/2013 | BRISTOL MYERS SQUIBB CO | BMY | Other (acquisition) | Performance Shares | 1.3k | $0.00 | $0 | | 03/07/2013 |
| 11/02/2012 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 3.1k | $33.18 | $102.6k | | 11/02/2012 |
| 11/02/2012 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 6.7k | $0.00 | $0 | | 11/02/2012 |
| 08/30/2012 | BRISTOL MYERS SQUIBB CO | BMY | Sale | Common Stock, $0.10 par value | 118.2k | $32.89 | $3.9M | | 08/30/2012 |
| 08/30/2012 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Option (right to buy) | 59.9k | $17.51 | $1M | | 08/30/2012 |
| 08/30/2012 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Option (right to buy) | 55.5k | $22.14 | $1.2M | | 08/30/2012 |
| 08/30/2012 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Option (right to buy) | 32.3k | $22.73 | $734.2k | | 08/30/2012 |
| 03/01/2011 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 5.2k | $25.58 | $133k | | 03/01/2011 |
| 03/01/2011 | BRISTOL MYERS SQUIBB CO | BMY | Payment of Exercise | Common Stock, $0.10 par value | 4.1k | $25.58 | $106k | | 03/01/2011 |